Safety and Efficacy of Raltegravir in HIV-Infected Transplant Patients Cotreated with Immunosuppressive Drugs

This publication has 11 references indexed in Scilit:

• Antiretroviral Treatment of Adult HIV Infection
  JAMA, 2008
• Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection
  New England Journal of Medicine, 2008
• Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation
  AIDS, 2008
• HIV-Infected Liver and Kidney Transplant Recipients: 1- and 3-Year Outcomes
  American Journal of Transplantation, 2008
• Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme
  Drug Metabolism and Disposition, 2007
• Effect of Highly Active Antiretroviral Therapy on Tacrolimus Pharmacokinetics in Hepatitis C Virus and HIV Co-Infected Liver Transplant Recipients in the ANRS HC-08 Study
  Clinical Pharmacokinetics, 2007
• Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients
  Kidney International, 2005
• Antiretroviral and immunosuppressive drug-drug interactions: An update
  Kidney International, 2004
• The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients
  Liver Transplantation, 2002
• Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA Cohort
  AIDS, 2002